eCTD Validation Playbook: How to Prevent Technical Rejection


Playbook · eCTD validation

Preventing technical rejection

How agencies validate a sequence, the defects that cause rejection, and the practices that keep them out of your submissions.

Validation report
Sequence 0007 — US
Graded at FDA severity
Sub-type not valid for submission typeEnvelope
High
Checksum mismatch — m3/32p/stability.pdfFile changed after build
High
Hyperlink target not foundm2/27-clin-sum/summary.pdf, page 14
Medium
Bookmarks missingm5/53-clin-stud-rep/csr-001.pdf
Low
Two high-severity findings: this sequence would be rejected.
How it works

Agencies validate before anyone reads

A failed sequence never reaches a reviewer, and the review clock does not start.

United States — FDA

Criteria graded high, medium or low. High-severity errors lead to technical rejection; separate criteria apply to study data.

European Union

Pass/fail plus best-practice criteria. Any pass/fail failure rejects the sequence. Criteria v8.2 mandatory from 1 December 2025.

Japan — PMDA

eCTD 4.0 check items published as configuration, including conditional rules and rules with effective dates.

Other regions

Each authority publishes its own criteria and severity — the same defect can be a warning in one region and a rejection in another.

What fails

The usual causes

Envelope

Wrong application number, sub-type not valid for the submission type, sequence number not matching its folder.

Files and checksums

A file edited after the backbone was built, or a file on disk the backbone does not list.

Lifecycle

A replace pointing at the wrong document. Often passes validation and confuses the reviewer instead.

PDF properties

Security settings, unembedded fonts, image-only pages, unsupported versions.

Navigation

Hyperlinks and bookmarks that go nowhere after a target was renamed or moved.

Specification drift

Templates still on a Module 1 or DTD version the region has retired.

Practices

What prevents it

Validate from the first draft

Run the region’s criteria every time the sequence changes, not the night before the deadline.

Build the envelope from data

From the application record and the region’s vocabularies — not typed into a form.

Fix at the source

Re-render from the corrected document, or the defect returns with the next version.

Validate what you receive

Run the same criteria on sequences from partners and previous vendors.

Full report · PDF

The full validation playbook

For publishing, regulatory operations and quality teams.

  1. How FDA, the EU, PMDA and other regions grade validation findings
  2. Nine defect categories, with typical defects and root causes
  3. Seven operating practices that prevent rejection
  4. PDF and navigation standards to author to from the start
  5. How to triage a validation report

PDF · October 2026 edition

Get the full report

Free PDF. Tell us where to send follow-up — we don’t share your details.

Your report is ready

The download should start automatically. If it doesn’t, use the button below.

Open the PDF →
Questions

Frequently asked

What is a technical rejection?

A refusal by the agency’s receiving system because the sequence fails rejection-level validation criteria. The content is not reviewed and the review clock does not start until a corrected sequence is accepted.

Are FDA and EU validation criteria the same?

No. FDA grades criteria by severity and rejects on high-severity errors; the EU uses pass/fail criteria, where any failure rejects, plus best-practice criteria. Each region publishes its own list.

Does passing validation mean the submission is right?

It means it is technically acceptable. It does not confirm that the right documents are in the right places with the right lifecycle, which still needs a review of the cumulative view.

How often do validation criteria change?

Regularly. The EU’s criteria v8.2 became mandatory on 1 December 2025, and other regions update on their own schedules. Check each region you file in at least twice a year.

Validation that runs while you build

DnXT Publisher checks each sequence against the target region’s own criteria as it is assembled, graded at that region’s own severity.